Drug recall · July 30, 2025
clomiPRAMINE Hydrochloride Capsules USP 25 mg recall
Why: Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01
- Lots / codes
Lot # M300464, exp. date June, 2025
- Quantity
- 2,724 bottles
- Company
- Lupin Pharmaceuticals Inc., Naples, FL
- Distribution
- Nationwide.
- Initiated
- June 27, 2025 · Voluntary: Firm initiated
- Classified
- July 21, 2025
- Reported
- July 30, 2025
- Ended
- January 5, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clomipramine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.